Found: 43
Select item for more details and to access through your institution.
Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00324
- By:
- Publication type:
- Article
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1.
- Published in:
- Orphanet Journal of Rare Diseases, 2012, v. 7, n. 1, p. 75, doi. 10.1186/1750-1172-7-75
- By:
- Publication type:
- Article
Fracture Risk in Pediatric Patients With MEN2B.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. e4371, doi. 10.1210/clinem/dgac500
- By:
- Publication type:
- Article
MEK inhibitio n exhibits efficacy in human and mouse neurofibromatosis tumors.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 1, p. 340, doi. 10.1172/JCI60578
- By:
- Publication type:
- Article
Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.
- Published in:
- American Journal of Medical Genetics. Part A, 2015, v. 167A, n. 9, p. 2103, doi. 10.1002/ajmg.a.37123
- By:
- Publication type:
- Article
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
- Published in:
- American Journal of Medical Genetics. Part A, 2014, v. 164A, n. 3, p. 563, doi. 10.1002/ajmg.a.36312
- By:
- Publication type:
- Article
Current status of MEK inhibitors in the treatment of plexiform neurofibromas.
- Published in:
- Child's Nervous System, 2020, v. 36, n. 10, p. 2443, doi. 10.1007/s00381-020-04731-2
- By:
- Publication type:
- Article
Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1.
- Published in:
- Journal of Neurosurgery, 2020, v. 133, n. 5, p. 1516, doi. 10.3171/2019.7.JNS191353
- By:
- Publication type:
- Article
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2621, doi. 10.3390/cancers15092621
- By:
- Publication type:
- Article
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).
- Published in:
- Sarcoma, 2019, p. 1, doi. 10.1155/2019/7656747
- By:
- Publication type:
- Article
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.
- Published in:
- Sarcoma, 2017, p. 1, doi. 10.1155/2017/8685638
- By:
- Publication type:
- Article
Audiometric and Otologic Findings in Children and Young Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas.
- Published in:
- Laryngoscope, 2023, v. 133, n. 10, p. 2770, doi. 10.1002/lary.30522
- By:
- Publication type:
- Article
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.
- Published in:
- Life Science Alliance, 2024, v. 7, n. 5, p. 1, doi. 10.26508/lsa.202302229
- By:
- Publication type:
- Article
Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1368, doi. 10.1093/neuonc/noaa053
- By:
- Publication type:
- Article
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1–associated atypical neurofibromas.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 8, p. 981, doi. 10.1093/neuonc/noz028
- By:
- Publication type:
- Article
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 12, p. 1643, doi. 10.1093/neuonc/noy067
- By:
- Publication type:
- Article
RARE-07. THE EFFECT OF SELUMETINIB ON SPINAL NEUROFIBROMAS IN PATIENTS WITH NF1.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi237, doi. 10.1093/neuonc/noy148.984
- By:
- Publication type:
- Article
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 6, p. 818, doi. 10.1093/neuonc/noy013
- By:
- Publication type:
- Article
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 289, doi. 10.1093/neuonc/now158
- By:
- Publication type:
- Article
Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 4, p. 596, doi. 10.1093/neuonc/nou235
- By:
- Publication type:
- Article
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 5, p. 707, doi. 10.1093/neuonc/nou004
- By:
- Publication type:
- Article
Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Social–emotional Functioning of Children and Adolescents With Neurofibromatosis Type 1 and Plexiform Neurofibromas: Relationships With Cognitive, Disease, and Environmental Variables.
- Published in:
- Journal of Pediatric Psychology, 2012, v. 37, n. 7, p. 713, doi. 10.1093/jpepsy/jsr124
- By:
- Publication type:
- Article
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 9, p. 1, doi. 10.1002/pbc.30358
- By:
- Publication type:
- Article
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 10, p. 1709, doi. 10.1002/pbc.25546
- By:
- Publication type:
- Article
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 9, p. 1598, doi. 10.1002/pbc.25041
- By:
- Publication type:
- Article
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: An NF clinical trials consortium phase II study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 6, p. 982, doi. 10.1002/pbc.24873
- By:
- Publication type:
- Article
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
- Published in:
- Acta Neuropathologica, 2013, v. 125, n. 1, p. 159, doi. 10.1007/s00401-012-1056-7
- By:
- Publication type:
- Article
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.
- Published in:
- Communications Biology, 2018, v. 1, n. 1, p. N.PAG, doi. 10.1038/s42003-018-0163-y
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 396, doi. 10.1002/pbc.24281
- By:
- Publication type:
- Article
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Preclincial testing of Sorafenib and RAD001 in the Nf<sup> flox/flox</sup> ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 2, p. 173, doi. 10.1002/pbc.23015
- By:
- Publication type:
- Article
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 167, n. 2, p. 339, doi. 10.1007/s11060-024-04596-4
- By:
- Publication type:
- Article
Characterization of spinal findings in children and adults with neurofibromatosis type 1 enrolled in a natural history study using magnetic resonance imaging.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 121, n. 1, p. 209, doi. 10.1007/s11060-014-1629-5
- By:
- Publication type:
- Article
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 87, n. 2, p. 165
- By:
- Publication type:
- Article
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 10, p. 1883, doi. 10.1093/neuonc/noad086
- By:
- Publication type:
- Article
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1845, doi. 10.1093/neuonc/noac165
- By:
- Publication type:
- Article
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1827, doi. 10.1093/neuonc/noac146
- By:
- Publication type:
- Article
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1978, doi. 10.1093/neuonc/noac109
- By:
- Publication type:
- Article
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 189, doi. 10.1177/17407745231206402
- By:
- Publication type:
- Article